Vitamin supplementation increases risk of subclinical mastitis in HIV-infected women.
Subclinical mastitis is common in HIV-infected women and is a risk factor for mother-to-child transmission of HIV. The purpose of this study was to examine the effect of vitamin supplementation [vitamin A + β-carotene, multivitamins (B complex, C, and E), or multivitamins, including vitamin A + β-carotene] on the risk of subclinical mastitis during the first 2 y postpartum among HIV-infected women. The study was a randomized, placebo-controlled, clinical trial including 674 HIV-infected, antiretroviral naïve Tanzanian women who were recruited during pregnancy and followed-up after delivery. Breast milk samples were obtained approximately every 3 mo. Any subclinical mastitis was defined as a ratio of the sodium to potassium (Na:K) breast milk concentrations > 0.6 and further classified as either moderate (Na:K ≥ 0.6 and ≤ 1) or severe (Na:K > 1.0). Fifty-eight percent of women had at least 1 episode of any subclinical mastitis. Women assigned to multivitamins (B complex, C, and E) had a 33% greater risk of any subclinical mastitis (P = 0.005) and a 75% greater risk of severe subclinical mastitis (P = 0.0006) than women who received the placebo. Vitamin A + β-carotene also increased the risk of severe subclinical mastitis by 45% (P = 0.03). Among women with CD4+ T-cell counts ≥ 350 cells/μL, multivitamin intake resulted in a 49% increased risk of any subclinical mastitis (P = 0.006); by contrast, there were no treatment effects among women with CD4+ T-cell counts < 350 cells/μL (P- interaction for treatment × CD4+ T-cell count = 0.10). Supplementation of HIV-infected women with vitamins increased the risk of subclinical mastitis.
Arsenault
Joanne E
JE
Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA.
Aboud
Said
S
Manji
Karim P
KP
Fawzi
Wafaie W
WW
Villamor
Eduardo
E
D000328:Adult; D018791:CD4 Lymphocyte Count; D019587:Dietary Supplements / Q000009:adverse effects; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008413:Mastitis / Q000175:diagnosis / Q000209:etiology*; D008895:Milk, Human / Q000737:chemistry; D010919:Placebos; D049590:Postpartum Period; D011188:Potassium / Q000032:analysis; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000821:virology; D012307:Risk Factors; D012964:Sodium / Q000032:analysis; D013636:Tanzania; D014801:Vitamin A / Q000008:administration & dosage / Q000009:adverse effects; D014815:Vitamins / Q000008:administration & dosage* / Q000009:adverse effects*; D019207:beta Carotene / Q000008:administration & dosage / Q000009:adverse effects
D010919:Placebos; D014815:Vitamins; D019207:beta Carotene; D014801:Vitamin A; D012964:Sodium; D011188:Potassium